7Juran JM, Gryna FM. Juran's quality control hand- book[M]. 4th Ed. New York: McGraw-Hill Profes- sional, 1988 .. 1-59.
8Dejaegher B, J imidar M,De Smet M, et al. Improving method capability of a drug substance HPLC assay [J]. J Pharm Biomed Anal,2006,42(2) :155-170.
9Kamberia M, Garciab H, Feder DP, et al. Setting ac- ceptance criteria for validation of analytical methods of drug eluting stents Minimum requirements for analytical variability[J]. Eur J Pharm Sci, 2011,42 (3) :230-237.
10Raska CS,Bennett TS, Goodberlet SA. Risk-based an- alytical method transfer: application to large multi- product transfers[J]. Anal Chem,2010,82(14) 5932- 5936.
